is semaglutide from a compounding pharmacy safe FDA moving to restrict mass-marketed compounded GLP-1 products that aren't FDA-approved, warning companies they can't market them as equivalent to approved drugs and signaling stronger enforcement to protect patients unverified Compounded Semaglutide & Tirzepatide 2025:

Current treatments offer limited efficacy, and the need for new therapeutic approaches is crucial

There have been reports of people accidentally taking a much larger dose than intended of compounded semaglutide or tirzepatide, leading to side effects like nausea, vomiting, and diarrhea sometimes so severe that they required hospitalization

Evidence that breast tissue stiffness is associated with risk of breast cancer

Research published in 2021 found that men whose partners had experienced a miscarriage had more than double the level of sperm DNA fragmentation compared to men in a fertile control group suggesting that sperm DNA damage may be a clinically relevant factor in early pregnancy loss